The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(3-(2-cyclopropoxypyridin-4-yl)-5-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yloxy)-2-methylpentan-2-ol ID: ALA4764221
PubChem CID: 162661098
Max Phase: Preclinical
Molecular Formula: C24H28N6O3
Molecular Weight: 448.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(-c2nc3c(-c4ccnc(OC5CC5)c4)cnn3cc2OCCCC(C)(C)O)cn1
Standard InChI: InChI=1S/C24H28N6O3/c1-24(2,31)8-4-10-32-20-15-30-23(28-22(20)17-12-26-29(3)14-17)19(13-27-30)16-7-9-25-21(11-16)33-18-5-6-18/h7,9,11-15,18,31H,4-6,8,10H2,1-3H3
Standard InChI Key: YFUNSPWUHJGDOO-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
20.0167 -24.0151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4978 -23.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0163 -22.6906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2680 -24.7908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7196 -25.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9718 -26.1747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7595 -26.3533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3194 -25.7327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0643 -24.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2381 -23.7624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2387 -22.9397 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5305 -22.5302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8172 -22.9387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8166 -23.7613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5293 -24.1754 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1092 -24.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3632 -23.8349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8153 -24.4412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2227 -25.1497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0223 -24.9811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0028 -24.3544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4208 -26.7783 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6227 -26.6030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0174 -26.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8421 -26.8531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1104 -22.5286 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.1121 -21.7114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4053 -21.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4070 -20.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7002 -20.0740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7019 -19.2568 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9916 -20.4811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1180 -19.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 1 2 0
1 2 1 0
2 3 2 0
3 11 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
1 4 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 16 1 0
14 16 1 0
18 21 1 0
6 22 1 0
22 23 1 0
24 23 1 0
25 24 1 0
23 25 1 0
13 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
30 32 1 0
30 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 448.53Molecular Weight (Monoisotopic): 448.2223AlogP: 3.66#Rotatable Bonds: 9Polar Surface Area: 99.59Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.03CX LogP: 2.87CX LogD: 2.87Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.39Np Likeness Score: -0.91
References 1. Miwa S,Yokota M,Ueyama Y,Maeda K,Ogoshi Y,Seki N,Ogawa N,Nishihata J,Nomura A,Adachi T,Kitao Y,Nozawa K,Ishikawa T,Ukaji Y,Shiozaki M. (2021) Discovery of Selective Transforming Growth Factor β Type II Receptor Inhibitors as Antifibrosis Agents., 12 (5.0): [PMID:34055221 ] [10.1021/acsmedchemlett.0c00679 ]